120 related articles for article (PubMed ID: 7704430)
1. Cyclic AMP-mediated desensitization of D1 dopamine receptor-coupled adenylyl cyclase in NS20Y neuroblastoma cells.
Black LE; Smyk-Randall EM; Sibley DR
Mol Cell Neurosci; 1994 Dec; 5(6):567-75. PubMed ID: 7704430
[TBL] [Abstract][Full Text] [Related]
2. Agonist-induced desensitization of D1-dopamine receptors linked to adenylyl cyclase activity in cultured NS20Y neuroblastoma cells.
Barton AC; Sibley DR
Mol Pharmacol; 1990 Oct; 38(4):531-41. PubMed ID: 1978240
[TBL] [Abstract][Full Text] [Related]
3. Altered regulation of the D(1) dopamine receptor in mutant Chinese hamster ovary cells deficient in cyclic AMP-dependent protein kinase activity.
Ventura AL; Sibley DR
J Pharmacol Exp Ther; 2000 May; 293(2):426-34. PubMed ID: 10773012
[TBL] [Abstract][Full Text] [Related]
4. Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells.
Barton AC; Black LE; Sibley DR
Mol Pharmacol; 1991 May; 39(5):650-8. PubMed ID: 1674585
[TBL] [Abstract][Full Text] [Related]
5. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
Law PY; Bergsbaken C
J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
[TBL] [Abstract][Full Text] [Related]
6. The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells.
Zhang LJ; Lachowicz JE; Sibley DR
Mol Pharmacol; 1994 May; 45(5):878-89. PubMed ID: 7910658
[TBL] [Abstract][Full Text] [Related]
7. Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636.
Lin CW; Bianchi BR; Miller TR; Stashko MA; Wang SS; Curzon P; Bednarz L; Asin KE; Britton DR
J Pharmacol Exp Ther; 1996 Mar; 276(3):1022-9. PubMed ID: 8786531
[TBL] [Abstract][Full Text] [Related]
8. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons.
Sasaki T; Kotera J; Omori K
J Neurochem; 2004 Apr; 89(2):474-83. PubMed ID: 15056290
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells.
Lin CW; Miller TR; Witte DG; Bianchi BR; Stashko M; Manelli AM; Frail DE
Mol Pharmacol; 1995 Jan; 47(1):131-9. PubMed ID: 7838121
[TBL] [Abstract][Full Text] [Related]
11. Homologous desensitization of the D1A dopamine receptor: efficacy in causing desensitization dissociates from both receptor occupancy and functional potency.
Lewis MM; Watts VJ; Lawler CP; Nichols DE; Mailman RB
J Pharmacol Exp Ther; 1998 Jul; 286(1):345-53. PubMed ID: 9655879
[TBL] [Abstract][Full Text] [Related]
12. Selective blockade of a slowly inactivating potassium current in striatal neurons by (+/-) 6-chloro-APB hydrobromide (SKF82958).
Nisenbaum ES; Mermelstein PG; Wilson CJ; Surmeier DJ
Synapse; 1998 Jul; 29(3):213-24. PubMed ID: 9635891
[TBL] [Abstract][Full Text] [Related]
13. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells.
Chern Y; Lai HL; Fong JC; Liang Y
Mol Pharmacol; 1993 Nov; 44(5):950-8. PubMed ID: 8246918
[TBL] [Abstract][Full Text] [Related]
14. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes.
Law PY; Hom DS; Loh HH
Mol Pharmacol; 1983 Nov; 24(3):413-24. PubMed ID: 6314114
[TBL] [Abstract][Full Text] [Related]
15. Sensitization of neuronal A2A adenosine receptors after persistent D2 dopamine receptor activation.
Vortherms TA; Watts VJ
J Pharmacol Exp Ther; 2004 Jan; 308(1):221-7. PubMed ID: 14566008
[TBL] [Abstract][Full Text] [Related]
16. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
Prather PL; Tsai AW; Law PY
J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
[TBL] [Abstract][Full Text] [Related]
17. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
Santanavanich C; Ebadi M; Govitrapong P
J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338
[TBL] [Abstract][Full Text] [Related]
18. Regulation of D(1) dopamine receptors with mutations of protein kinase phosphorylation sites: attenuation of the rate of agonist-induced desensitization.
Jiang D; Sibley DR
Mol Pharmacol; 1999 Oct; 56(4):675-83. PubMed ID: 10496949
[TBL] [Abstract][Full Text] [Related]
19. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
O'Sullivan GJ; Roth BL; Kinsella A; Waddington JL
Eur J Pharmacol; 2004 Feb; 486(3):273-80. PubMed ID: 14985049
[TBL] [Abstract][Full Text] [Related]
20. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
